EZH2 was found to be overexpressed in MDS tumor cells associated with methylation of tumor suppressor gene cyclin dependent kinase inhibitor 2B (p15INK4B) compared with tumor cells that p15INK4B is not methylated. This evidence concerns the gene CDKN2B and myelodysplastic syndrome.